The Boston Scientific-backed medical device maker has filed to raise up to $100m in an offering on the Nasdaq Global Market.
Nalu Medical, a US-based pain management system producer backed by fellow medical device manufacturer Boston Scientific Corporation, has filed to raise $100m in an initial public offering.
Founded in 2014, Nalu is commercialising an implantable pulse generator (IPG) device commercially launched in the second half of 2020 that can regulate pain signals sent to the brain by delivering electrical pulses to the nervous system.
The product can address chronic pain conditions through spinal cord stimulation and peripheral nerve stimulation.…
